Viewing Study NCT00645905


Ignite Creation Date: 2025-12-25 @ 3:23 AM
Ignite Modification Date: 2026-03-07 @ 11:01 PM
Study NCT ID: NCT00645905
Status: COMPLETED
Last Update Posted: 2008-03-28
First Post: 2008-03-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Sponsor: Abbott
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module